首页 > 最新文献

Acta medica Okayama最新文献

英文 中文
Effects of Thoron Inhalation and Cyclosporin A Treatment on Dextran Sulfate Sodium-Induced Oxidative Damage in Mice. 吸入刺龙和环孢素A对硫酸葡聚糖钠诱导小鼠氧化损伤的影响。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.18926/AMO/69844
Ayumi Tanaka, Shota Naoe, Reiju Takenaka, Norie Kanzaki, Akihiro Sakoda, Kiyonori Yamaoka, Takahiro Kataoka

Radon (222Rn; Rn) and thoron (220Rn; Tn) inhalation have been reported to enhance antioxidant activity in various organs. However, the effects of Tn on the colon have not been investigated. This study aimed to clarify the effects of Tn inhalation, alone and in combination with cyclosporin A (CsA), on dextran sulfate sodium (DSS)-induced colitis, and the accompanying oxidative stress, in mice. Male BALB/c mice were subjected to continuous 8-day Tn inhalation (c-Tn, 533±128 Bq/m3) or alternate-day Tn inhalation over the same period (f-Tn, 577±63Bq/m3), followed by treatment with 3% DSS and either CsA or vehicle for 7 days. Although the disease activity index (DAI) decreased significantly by day 2 in the c-Tn group, scores remained significantly higher than those in the f-Tn group. In the c-Tn group, superoxide dismutase and catalase activity in the colon were significantly elevated compared with those in sham controls. Thus, DSS-induced damage was effectively inhibited in the earlier stages by the c-Tn mode of inhalation than by the f-Tn mode. These findings suggest that continuous Tn inhalation more effectively attenuated early colitis symptoms than alternate-day inhalation, potentially through upregulation of antioxidant defenses. Tn and CsA showed no combined effects.

据报道,吸入氡(222Rn; Rn)和钍(220Rn; Tn)可增强各器官的抗氧化活性。然而,Tn对结肠的影响尚未被研究。本研究旨在阐明Tn单独吸入和与环孢素A (CsA)联合吸入对小鼠葡聚糖硫酸钠(DSS)诱导的结肠炎及其氧化应激的影响。雄性BALB/c小鼠连续吸入8天Tn (c-Tn, 533±128 Bq/m3)或同期隔天吸入Tn (f-Tn, 577±63Bq/m3),然后用3% DSS和CsA或载药治疗7天。尽管c-Tn组的疾病活动指数(DAI)在第2天显著下降,但评分仍明显高于f-Tn组。与对照组相比,c-Tn组结肠超氧化物歧化酶和过氧化氢酶活性显著升高。因此,吸入c-Tn比吸入f-Tn更能在早期有效地抑制dss引起的损伤。这些发现表明,连续吸入Tn比隔天吸入更有效地减轻早期结肠炎症状,可能是通过上调抗氧化防御。Tn和CsA无联合效应。
{"title":"Effects of Thoron Inhalation and Cyclosporin A Treatment on Dextran Sulfate Sodium-Induced Oxidative Damage in Mice.","authors":"Ayumi Tanaka, Shota Naoe, Reiju Takenaka, Norie Kanzaki, Akihiro Sakoda, Kiyonori Yamaoka, Takahiro Kataoka","doi":"10.18926/AMO/69844","DOIUrl":"https://doi.org/10.18926/AMO/69844","url":null,"abstract":"<p><p>Radon (222Rn; Rn) and thoron (220Rn; Tn) inhalation have been reported to enhance antioxidant activity in various organs. However, the effects of Tn on the colon have not been investigated. This study aimed to clarify the effects of Tn inhalation, alone and in combination with cyclosporin A (CsA), on dextran sulfate sodium (DSS)-induced colitis, and the accompanying oxidative stress, in mice. Male BALB/c mice were subjected to continuous 8-day Tn inhalation (c-Tn, 533±128 Bq/m3) or alternate-day Tn inhalation over the same period (f-Tn, 577±63Bq/m3), followed by treatment with 3% DSS and either CsA or vehicle for 7 days. Although the disease activity index (DAI) decreased significantly by day 2 in the c-Tn group, scores remained significantly higher than those in the f-Tn group. In the c-Tn group, superoxide dismutase and catalase activity in the colon were significantly elevated compared with those in sham controls. Thus, DSS-induced damage was effectively inhibited in the earlier stages by the c-Tn mode of inhalation than by the f-Tn mode. These findings suggest that continuous Tn inhalation more effectively attenuated early colitis symptoms than alternate-day inhalation, potentially through upregulation of antioxidant defenses. Tn and CsA showed no combined effects.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"79 6","pages":"421-429"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 and the Risks of Migraine and Headache: A Mendelian Randomization Study. COVID-19与偏头痛和头痛的风险:一项孟德尔随机研究。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.18926/AMO/69843
Zhiyun Jiang, Ying Xi

Several observational studies suggested that migraine headache attacks were associated with coronavirus disease 2019 (COVID-19). We investigated genetic causal links between COVID-19 phenotypes and the development of headache and migraine, including migraine with aura (MA) and migraine without aura (MO). We conducted a two-sample Mendelian randomization (MR) analysis to estimate the genetic association in European populations. The inverse-variance weighted (IVW) method was used as the main approach in the MR analyses, together with weighted median and MR-Egger methods. We also performed a series of sensitivity tests to assess the robustness of the MR results. The MR results demonstrated that COVID-19 severity, hospitalization, and susceptibility had no causal effect on the risks of headache, migraine, MA, or MO. No horizontal pleiotropy was detected, and the results were robust as supported by the sensitivity analysis findings. Our analyses identified no casual effect of COVID-19 severity, hospitalization, or susceptibility on the risks of headache or migraine in European populations.

几项观察性研究表明,偏头痛发作与2019冠状病毒病(COVID-19)有关。我们研究了COVID-19表型与头痛和偏头痛发展之间的遗传因果关系,包括先兆偏头痛(MA)和无先兆偏头痛(MO)。我们进行了一项双样本孟德尔随机化(MR)分析,以估计欧洲人群的遗传关联。MR分析主要采用反方差加权(IVW)法,加权中位数法和MR- egger法。我们还进行了一系列敏感性测试,以评估MR结果的稳健性。MR结果显示,COVID-19的严重程度、住院和易感性对头痛、偏头痛、MA或MO的风险没有因果影响。未检测到水平多效性,敏感性分析结果支持了结果的稳健性。我们的分析发现,在欧洲人群中,COVID-19的严重程度、住院治疗或易感性对头痛或偏头痛的风险没有偶然影响。
{"title":"COVID-19 and the Risks of Migraine and Headache: A Mendelian Randomization Study.","authors":"Zhiyun Jiang, Ying Xi","doi":"10.18926/AMO/69843","DOIUrl":"https://doi.org/10.18926/AMO/69843","url":null,"abstract":"<p><p>Several observational studies suggested that migraine headache attacks were associated with coronavirus disease 2019 (COVID-19). We investigated genetic causal links between COVID-19 phenotypes and the development of headache and migraine, including migraine with aura (MA) and migraine without aura (MO). We conducted a two-sample Mendelian randomization (MR) analysis to estimate the genetic association in European populations. The inverse-variance weighted (IVW) method was used as the main approach in the MR analyses, together with weighted median and MR-Egger methods. We also performed a series of sensitivity tests to assess the robustness of the MR results. The MR results demonstrated that COVID-19 severity, hospitalization, and susceptibility had no causal effect on the risks of headache, migraine, MA, or MO. No horizontal pleiotropy was detected, and the results were robust as supported by the sensitivity analysis findings. Our analyses identified no casual effect of COVID-19 severity, hospitalization, or susceptibility on the risks of headache or migraine in European populations.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"79 6","pages":"413-419"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ileus Tube-Related Intussusception: A Case Report and Review of 80 Previously Reported Cases. 肠梗阻管相关性肠套叠:一例报告并回顾80例既往报道。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.18926/AMO/69851
Teruyuki Tsujii, Tatsuo Matsuda, Yuji Kimura, Ryoichi Katsube, Hironori Iwadou, Sadami Funabiki, Yasuaki Kamikawa, Tadakazu Matsuda

We report a rare case of ileus tube-related intussusception in an adult. A 56-year-old man with adhesive bowel obstruction was treated with a nasointestinal ileus tube. Although his condition initially improved, persistent abdominal pain led to the diagnosis of intussusception via CT imaging. Manual repositioning of the tube resolved the intussusception without the need for bowel resection. A review of 80 previously reported cases of ileus tube-associated intussusception (total 81 cases, 95 lesions) highlighted the timing of onset, treatment strategies, and precautions. Early detection and diagnosis are crucial to prevent severe complications and preserve bowel function.

我们报告一例罕见的成人肠梗阻管相关肠套叠。一位56岁的男性粘连性肠梗阻的治疗鼻肠肠梗阻管。虽然他的病情最初有所改善,但持续的腹痛导致CT成像诊断为肠套叠。手动重新置管解决肠套叠,无需肠切除术。回顾了80例先前报道的肠梗阻管相关性肠套叠(共81例,95个病变),强调了发病时间,治疗策略和预防措施。早期发现和诊断对于预防严重并发症和保持肠道功能至关重要。
{"title":"Ileus Tube-Related Intussusception: A Case Report and Review of 80 Previously Reported Cases.","authors":"Teruyuki Tsujii, Tatsuo Matsuda, Yuji Kimura, Ryoichi Katsube, Hironori Iwadou, Sadami Funabiki, Yasuaki Kamikawa, Tadakazu Matsuda","doi":"10.18926/AMO/69851","DOIUrl":"10.18926/AMO/69851","url":null,"abstract":"<p><p>We report a rare case of ileus tube-related intussusception in an adult. A 56-year-old man with adhesive bowel obstruction was treated with a nasointestinal ileus tube. Although his condition initially improved, persistent abdominal pain led to the diagnosis of intussusception via CT imaging. Manual repositioning of the tube resolved the intussusception without the need for bowel resection. A review of 80 previously reported cases of ileus tube-associated intussusception (total 81 cases, 95 lesions) highlighted the timing of onset, treatment strategies, and precautions. Early detection and diagnosis are crucial to prevent severe complications and preserve bowel function.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"79 6","pages":"469-474"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration in Patients Aged 85 or Older. 抗血管内皮生长因子治疗85岁及以上患者新生血管性年龄相关性黄斑变性的实际结果
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.18926/AMO/69842
Chihiro Ouchi, Mio Morizane Hosokawa, Shuhei Kimura, Yusuke Shiode, Ryo Matoba, Tetsuro Morita, Yuki Morizane

We investigated the treatment outcomes of patients aged ≥85 years with neovascular age-related macular degeneration (nAMD) who received anti-vascular endothelial growth factor (anti-VEGF) therapy using either treat-and-extend (TAE) or pro re nata (PRN) regimens for 1 year in real-world clinical practice. Eighty-five eyes from 85 patients were included. Among them, types 1, 2, and 3 macular neovascularization and polypoidal choroidal vasculopathy were present in 27.1%, 17.6%, 18.8%, and 36.5%, respectively. TAE and PRN regimens were used in 43.5% and 56.5% of patients, respectively. At baseline, the PRN group was older and had worse best-corrected visual acuity (BCVA), greater central retinal thickness, and more intraretinal fluid than the TAE group. In the TAE group, the mean number of injections was 7.6, BCVA improved significantly, and all retinal fluid rates decreased. In the PRN group, the mean number of injections was 3.9, BCVA remained unchanged, and the rates of macular fibrosis and atrophy increased. No serious adverse events were observed in either group. Anti-VEGF therapy was safe for patients aged ≥ 85 years with nAMD, and the TAE regimen effectively improved BCVA in this population. BCVA remained unchanged in the PRN-treated patients, with baseline disease severity and/or undertreatment potentially influencing the outcomes.

我们在现实世界的临床实践中研究了年龄≥85岁的新生血管性年龄相关性黄斑变性(nAMD)患者接受抗血管内皮生长因子(anti-VEGF)治疗,使用治疗延长(TAE)或恢复(PRN)方案1年的治疗结果。85名患者的85只眼睛被纳入研究。其中,1、2、3型黄斑新生血管和息肉样脉络膜血管病变分别占27.1%、17.6%、18.8%和36.5%。分别有43.5%和56.5%的患者使用TAE和PRN方案。在基线时,PRN组比TAE组年龄更大,最佳矫正视力(BCVA)更差,视网膜中央厚度更大,视网膜内积液更多。TAE组平均注射次数为7.6次,BCVA明显改善,所有视网膜液率均下降。在PRN组中,平均注射次数为3.9次,BCVA保持不变,黄斑纤维化和萎缩率增加。两组均未见严重不良事件发生。抗vegf治疗对于年龄≥85岁的nAMD患者是安全的,TAE方案有效改善了该人群的BCVA。在prn治疗的患者中,BCVA保持不变,基线疾病严重程度和/或治疗不足可能影响结果。
{"title":"Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration in Patients Aged 85 or Older.","authors":"Chihiro Ouchi, Mio Morizane Hosokawa, Shuhei Kimura, Yusuke Shiode, Ryo Matoba, Tetsuro Morita, Yuki Morizane","doi":"10.18926/AMO/69842","DOIUrl":"https://doi.org/10.18926/AMO/69842","url":null,"abstract":"<p><p>We investigated the treatment outcomes of patients aged ≥85 years with neovascular age-related macular degeneration (nAMD) who received anti-vascular endothelial growth factor (anti-VEGF) therapy using either treat-and-extend (TAE) or pro re nata (PRN) regimens for 1 year in real-world clinical practice. Eighty-five eyes from 85 patients were included. Among them, types 1, 2, and 3 macular neovascularization and polypoidal choroidal vasculopathy were present in 27.1%, 17.6%, 18.8%, and 36.5%, respectively. TAE and PRN regimens were used in 43.5% and 56.5% of patients, respectively. At baseline, the PRN group was older and had worse best-corrected visual acuity (BCVA), greater central retinal thickness, and more intraretinal fluid than the TAE group. In the TAE group, the mean number of injections was 7.6, BCVA improved significantly, and all retinal fluid rates decreased. In the PRN group, the mean number of injections was 3.9, BCVA remained unchanged, and the rates of macular fibrosis and atrophy increased. No serious adverse events were observed in either group. Anti-VEGF therapy was safe for patients aged ≥ 85 years with nAMD, and the TAE regimen effectively improved BCVA in this population. BCVA remained unchanged in the PRN-treated patients, with baseline disease severity and/or undertreatment potentially influencing the outcomes.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"79 6","pages":"405-412"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frailty at 1 Month before ICU Admission Poses a Hospital Mortality Risk in Cancer Survivors whose Condition Has Deteriorated due to Medical Factors. 因医疗因素导致病情恶化的癌症幸存者入院前1个月的虚弱增加了住院死亡风险。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.18926/AMO/69846
Junya Matsumi, Tetsufumi Sato

The optimal indications for intensive care unit (ICU) treatment for critically ill cancer survivors whose condition has deteriorated due to medical factors are unclear. To test our hypothesis that frailty before deterioration was associated with hospital mortality in this patient population, we retrospective analyzed the cases of the patients admitted to the ICU at the National Cancer Center Hospital, Japan (April 2014-March 2022). We excluded patients who underwent surgery within 28 days or were denied critical care within 24 h or admitted after cardiopulmonary arrest. Their Clinical Frailty Scale (CFS) scores at 1 month before ICU admission (Pre-ICU) were obtained. Frailty was defined as CFS scores ≥4 points. We analyzed 298 admissions and observed that the mortality rate at hospital discharge was significantly higher in the frailty group (n=119). A multivariate analysis demonstrated that the following factors were significantly associated with hospital mortality: Pre-ICU frailty (OR 2.00, 95%CI: 1.19-3.36, p=0.009), cancer type (hematological: OR 2.93, 95%CI: 1.42-6.05, p=0.004), and Sequential Organ Failure Assessment score at ICU admission (OR 0.88, 95%CI: 0.82-0.95, p=0.0008). Frailty retrospectively assessed using the CFS at 1 month pre-ICU admission is a risk factor for hospital mortality in these cancer survivors.

重症监护病房(ICU)治疗因医学因素导致病情恶化的危重癌症幸存者的最佳适应症尚不清楚。为了验证我们的假设,即恶化前的虚弱与该患者群体的住院死亡率相关,我们回顾性分析了2014年4月至2022年3月期间日本国立癌症中心医院ICU收治的患者病例。我们排除了28天内接受手术或24小时内拒绝重症监护或心肺骤停后入院的患者。获得患者入ICU前1个月的临床虚弱量表(CFS)评分。虚弱定义为CFS评分≥4分。我们分析了298例入院患者,观察到虚弱组的出院死亡率明显更高(n=119)。多因素分析显示,以下因素与住院死亡率显著相关:ICU前虚弱(OR 2.00, 95%CI: 1.19-3.36, p=0.009)、癌症类型(血液学:OR 2.93, 95%CI: 1.42-6.05, p=0.004)、ICU入院时序贯器官衰竭评估评分(OR 0.88, 95%CI: 0.82-0.95, p=0.0008)。在icu入院前1个月使用CFS回顾性评估的虚弱是这些癌症幸存者住院死亡的危险因素。
{"title":"Frailty at 1 Month before ICU Admission Poses a Hospital Mortality Risk in Cancer Survivors whose Condition Has Deteriorated due to Medical Factors.","authors":"Junya Matsumi, Tetsufumi Sato","doi":"10.18926/AMO/69846","DOIUrl":"https://doi.org/10.18926/AMO/69846","url":null,"abstract":"<p><p>The optimal indications for intensive care unit (ICU) treatment for critically ill cancer survivors whose condition has deteriorated due to medical factors are unclear. To test our hypothesis that frailty before deterioration was associated with hospital mortality in this patient population, we retrospective analyzed the cases of the patients admitted to the ICU at the National Cancer Center Hospital, Japan (April 2014-March 2022). We excluded patients who underwent surgery within 28 days or were denied critical care within 24 h or admitted after cardiopulmonary arrest. Their Clinical Frailty Scale (CFS) scores at 1 month before ICU admission (Pre-ICU) were obtained. Frailty was defined as CFS scores ≥4 points. We analyzed 298 admissions and observed that the mortality rate at hospital discharge was significantly higher in the frailty group (n=119). A multivariate analysis demonstrated that the following factors were significantly associated with hospital mortality: Pre-ICU frailty (OR 2.00, 95%CI: 1.19-3.36, p=0.009), cancer type (hematological: OR 2.93, 95%CI: 1.42-6.05, p=0.004), and Sequential Organ Failure Assessment score at ICU admission (OR 0.88, 95%CI: 0.82-0.95, p=0.0008). Frailty retrospectively assessed using the CFS at 1 month pre-ICU admission is a risk factor for hospital mortality in these cancer survivors.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"79 6","pages":"437-444"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative Team Management Was Beneficially Associated with Prolonged Postoperative Hospital Stays after Long Lower-Abdominal Surgeries. 围手术期团队管理有利于延长下腹长时间手术后的住院时间。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.18926/AMO/69847
Junya Matsumi

Our hospital began a PERIO program (perioperative patient management by a multi-disciplinary team from multiple departments) in 2016 to improve patient outcomes. We retrospectively analyzed the clinical effects of the PERIO program regarding the postoperative hospital stay (PHS) in the patients aged ≥ 18 years who underwent long lower-abdominal surgery at our hospital during the period April 2019 to March 2023. We excluded the cases of patients whose general anesthesia use was < 8 h, those for whom another surgery was performed simultaneously at another site, and emergency surgeries. The outcome was prolonged PHS, defined as exceeding the scheduled number of days specified in the patient's clinical pathway. Among the 480 patients, prolonged PHS was observed for 270 patients (56.3%). In a multivariate logistic regression using advanced age, sex, high-risk general state, surgery requiring colon resection, serious adverse events (SAEs), and PERIO use, the following were associated with prolonged PHS: advance age (odds ratio [OR] 4.91, 95% confidence interval [CI]: 2.68-8.99, p=0.01), surgery requiring colon resection (OR 4.91, 95%CI: 2.68-8.99, p<0.001), SAE (OR 18.7, 95%CI: 7.22-48.2, p<0.001), and PERIO (OR 0.25, 95%CI: 0.13-0.47, p<0.001). The use of the PERIO program was thus beneficially associated with PHS after long lower-abdominal surgery.

我院于2016年启动了PERIO项目(由多科室多学科团队进行围手术期患者管理),以改善患者预后。我们回顾性分析了2019年4月至2023年3月期间在我院接受长时间下腹手术的≥18岁患者的PERIO方案对术后住院时间(PHS)的临床效果。我们排除了全麻时间< 8小时的患者、在其他部位同时进行其他手术的患者以及紧急手术的患者。结果是延长PHS,定义为超过患者临床路径指定的预定天数。480例患者中有270例(56.3%)出现PHS延长。在使用高龄、性别、高危一般状态、需要结肠切除术的手术、严重不良事件(SAEs)和围手术期的多因素logistic回归中,以下因素与PHS延长相关:高龄(优势比[OR] 4.91, 95%可信区间[CI]: 2.68-8.99, p=0.01),需要结肠切除术的手术(OR 4.91, 95%CI: 2.68-8.99, p=0.01)
{"title":"Perioperative Team Management Was Beneficially Associated with Prolonged Postoperative Hospital Stays after Long Lower-Abdominal Surgeries.","authors":"Junya Matsumi","doi":"10.18926/AMO/69847","DOIUrl":"https://doi.org/10.18926/AMO/69847","url":null,"abstract":"<p><p>Our hospital began a PERIO program (perioperative patient management by a multi-disciplinary team from multiple departments) in 2016 to improve patient outcomes. We retrospectively analyzed the clinical effects of the PERIO program regarding the postoperative hospital stay (PHS) in the patients aged ≥ 18 years who underwent long lower-abdominal surgery at our hospital during the period April 2019 to March 2023. We excluded the cases of patients whose general anesthesia use was < 8 h, those for whom another surgery was performed simultaneously at another site, and emergency surgeries. The outcome was prolonged PHS, defined as exceeding the scheduled number of days specified in the patient's clinical pathway. Among the 480 patients, prolonged PHS was observed for 270 patients (56.3%). In a multivariate logistic regression using advanced age, sex, high-risk general state, surgery requiring colon resection, serious adverse events (SAEs), and PERIO use, the following were associated with prolonged PHS: advance age (odds ratio [OR] 4.91, 95% confidence interval [CI]: 2.68-8.99, p=0.01), surgery requiring colon resection (OR 4.91, 95%CI: 2.68-8.99, p<0.001), SAE (OR 18.7, 95%CI: 7.22-48.2, p<0.001), and PERIO (OR 0.25, 95%CI: 0.13-0.47, p<0.001). The use of the PERIO program was thus beneficially associated with PHS after long lower-abdominal surgery.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"79 6","pages":"445-449"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MRI Images of a Case of Adenocarcinoma, Human Papillomavirus-Independent, Mesonephric Type, of the Uterine Cervix. 不依赖人乳头瘤病毒的中肾型子宫颈腺癌1例的MRI影像。
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.18926/AMO/69850
Yudai Asano, Chika Nishihara, Takahiro Kitayama, Nanako Okawa, Satoko Makimoto, Fumiyo Higaki, Katsuhide Kojima, Hanako Sugihara, Naoyuki Ida, Hiroyuki Yanai, Takao Hiraki

We present a case of a woman in her 70s who was diagnosed with mesonephric adenocarcinoma of the uterine cervix, following biopsy and surgery. Preoperative MRI revealed a 7-cm, well-defined circumferential cervical mass with left lateral wall predominance, bulging into the uterine cavity and vagina. The lesion showed intermediate signal intensity on T2-weighted images, diffusion restriction, and early contrast enhancement weaker than that of the myometrium, followed by washout on contrast-enhanced imaging. The circumferential growth pattern with the lateral wall predominance and its imaging characteristics may suggest this rare entity be routinely included in the differential diagnosis of cervical cancers.

我们提出一个病例的妇女在她的70谁被诊断为子宫内膜腺癌的子宫颈,活检和手术后。术前MRI显示一个7厘米,边界明确的宫颈肿块,以左侧壁为主,向子宫腔和阴道内膨出。病变在t2加权图像上表现为中等信号强度,扩散受限,早期对比增强弱于肌层,随后增强成像为冲洗。以外侧壁为主的周向生长模式及其影像学特征可能提示这种罕见的实体应常规纳入宫颈癌的鉴别诊断。
{"title":"MRI Images of a Case of Adenocarcinoma, Human Papillomavirus-Independent, Mesonephric Type, of the Uterine Cervix.","authors":"Yudai Asano, Chika Nishihara, Takahiro Kitayama, Nanako Okawa, Satoko Makimoto, Fumiyo Higaki, Katsuhide Kojima, Hanako Sugihara, Naoyuki Ida, Hiroyuki Yanai, Takao Hiraki","doi":"10.18926/AMO/69850","DOIUrl":"https://doi.org/10.18926/AMO/69850","url":null,"abstract":"<p><p>We present a case of a woman in her 70s who was diagnosed with mesonephric adenocarcinoma of the uterine cervix, following biopsy and surgery. Preoperative MRI revealed a 7-cm, well-defined circumferential cervical mass with left lateral wall predominance, bulging into the uterine cavity and vagina. The lesion showed intermediate signal intensity on T2-weighted images, diffusion restriction, and early contrast enhancement weaker than that of the myometrium, followed by washout on contrast-enhanced imaging. The circumferential growth pattern with the lateral wall predominance and its imaging characteristics may suggest this rare entity be routinely included in the differential diagnosis of cervical cancers.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"79 6","pages":"463-468"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exacerbation of Proteinuria in a Patient with Behçet's Disease and IgA Nephropathy Following Colchicine Discontinuation. 秋水仙碱停药后behet病和IgA肾病患者蛋白尿加重
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.18926/AMO/69849
Tomohiko Asakawa, Haruhito A Uchida, Yu Katayama, Yoshimasa Sakurabu, Katsuyoshi Katayama, Yasuhiro Onishi, Natsumi Matsuoka-Uchiyama, Hidemi Takeuchi, Keiko Tanaka, Kenji Tsuji, Ryoko Umebayashi, Rika Takemoto, Jun Wada

This case involves a 23-year-old male who was diagnosed with Behçet's disease 5 years ago and managed with colchicine. Two months ago, he underwent renal biopsy due to abnormal urinalysis and kidney dysfunction, leading to a diagnosis of IgA nephropathy. He subsequently underwent tonsillectomy followed by glucocorticoid pulse therapy. However, after the tonsillectomy, discontinuing colchicine led to increased proteinuria, despite the glucocorticoid pulse therapy. Upon reintroducing colchicine, urinary protein excretion decreased, achieving incomplete remission. These findings suggest that colchicine may be effective in decreasing proteinuria in patients with Behçet's disease complicated by IgA nephropathy.

该病例涉及一名23岁男性,5年前被诊断为behaperet病,并使用秋水仙碱治疗。两个月前,由于尿分析异常和肾功能不全,他接受了肾活检,诊断为IgA肾病。随后接受扁桃体切除术和糖皮质激素脉冲治疗。然而,扁桃体切除术后,停用秋水仙碱导致蛋白尿增加,尽管糖皮质激素脉冲治疗。重新引入秋水仙碱后,尿蛋白排泄减少,达到不完全缓解。这些发现提示秋水仙碱可能有效地减少behet病合并IgA肾病患者的蛋白尿。
{"title":"Exacerbation of Proteinuria in a Patient with Behçet's Disease and IgA Nephropathy Following Colchicine Discontinuation.","authors":"Tomohiko Asakawa, Haruhito A Uchida, Yu Katayama, Yoshimasa Sakurabu, Katsuyoshi Katayama, Yasuhiro Onishi, Natsumi Matsuoka-Uchiyama, Hidemi Takeuchi, Keiko Tanaka, Kenji Tsuji, Ryoko Umebayashi, Rika Takemoto, Jun Wada","doi":"10.18926/AMO/69849","DOIUrl":"https://doi.org/10.18926/AMO/69849","url":null,"abstract":"<p><p>This case involves a 23-year-old male who was diagnosed with Behçet's disease 5 years ago and managed with colchicine. Two months ago, he underwent renal biopsy due to abnormal urinalysis and kidney dysfunction, leading to a diagnosis of IgA nephropathy. He subsequently underwent tonsillectomy followed by glucocorticoid pulse therapy. However, after the tonsillectomy, discontinuing colchicine led to increased proteinuria, despite the glucocorticoid pulse therapy. Upon reintroducing colchicine, urinary protein excretion decreased, achieving incomplete remission. These findings suggest that colchicine may be effective in decreasing proteinuria in patients with Behçet's disease complicated by IgA nephropathy.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"79 6","pages":"457-461"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrence of FVIII Inhibitor during Surgery in a Patient with Severe Hemophilia A Receiving Emicizumab Prophylaxis. 接受Emicizumab预防的严重a型血友病患者手术期间FVIII抑制剂复发
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.18926/AMO/69848
Moe Hagihara, Keisuke Seike, Kenta Hayashino, Takao Yasuhara, Kyohei Kin, Yuichi Hirata, Hiroki Kobayashi, Wataru Kitamura, Hideaki Fujiwara, Noboru Asada, Nobuharu Fujii, Yoshinobu Maeda

Emicizumab, a bispecific monoclonal antibody, benefits patients with severe hemophilia A. It alters laboratory assessments of coagulation activity, requiring anti-idiotype monoclonal antibodies for accurate monitoring. A 64-year-old man, receiving emicizumab regularly, was admitted for laminoplasty. We planned to use FVIII replacement during the perioperative period after confirming the disappearance of inhibitors, monitoring coagulation activity with anti-idiotype monoclonal antibodies. Activated partial thromboplastin time was prolonged on postoperative day 2, prompting an immediate switch to eptacog alfa. The patient recovered without bleeding. This case underscores the necessity of anti-idiotype monoclonal antibodies for accurate monitoring.

Emicizumab是一种双特异性单克隆抗体,对严重a型血友病患者有益。它改变了实验室对凝血活性的评估,需要抗独特型单克隆抗体进行准确监测。一名64岁男性,定期接受emicizumab治疗,接受椎板成形术。我们计划在确认抑制剂消失后,在围手术期使用FVIII替代,用抗独特型单克隆抗体监测凝血活性。术后第2天活化部分凝血活素时间延长,提示立即切换到eptacog α。病人痊愈了,没有出血。该病例强调了精确监测抗独特型单克隆抗体的必要性。
{"title":"Recurrence of FVIII Inhibitor during Surgery in a Patient with Severe Hemophilia A Receiving Emicizumab Prophylaxis.","authors":"Moe Hagihara, Keisuke Seike, Kenta Hayashino, Takao Yasuhara, Kyohei Kin, Yuichi Hirata, Hiroki Kobayashi, Wataru Kitamura, Hideaki Fujiwara, Noboru Asada, Nobuharu Fujii, Yoshinobu Maeda","doi":"10.18926/AMO/69848","DOIUrl":"https://doi.org/10.18926/AMO/69848","url":null,"abstract":"<p><p>Emicizumab, a bispecific monoclonal antibody, benefits patients with severe hemophilia A. It alters laboratory assessments of coagulation activity, requiring anti-idiotype monoclonal antibodies for accurate monitoring. A 64-year-old man, receiving emicizumab regularly, was admitted for laminoplasty. We planned to use FVIII replacement during the perioperative period after confirming the disappearance of inhibitors, monitoring coagulation activity with anti-idiotype monoclonal antibodies. Activated partial thromboplastin time was prolonged on postoperative day 2, prompting an immediate switch to eptacog alfa. The patient recovered without bleeding. This case underscores the necessity of anti-idiotype monoclonal antibodies for accurate monitoring.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"79 6","pages":"451-455"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Weekend Admission and In-Hospital Mortality in Adult Patients with Acute Myeloid Leukemia in Japan. 日本成年急性髓性白血病患者周末入院与住院死亡率的关系
IF 0.6 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 DOI: 10.18926/AMO/69845
Takahiro Inoue, Hiroyo Kuwabara, Koh Yamamoto

The effect of weekend admission on patient mortality has been investigated in several therapeutic areas, including acute myeloid leukemia (AML), but the investigations' results are controversial. We evaluated the relationship between in-hospital mortality and weekend admission in adult patients with AML in Japan by conducting a retrospective observational study using administrative data from 144 acute care hospitals from which patients were discharged between April 2014 and March 2019. The primary endpoint was in-hospital mortality, compared between weekend and weekday admissions. Among the 1,340 eligible patients, 11% (150) were admitted during a weekend. The in-hospital mortality rates of the patients admitted during weekends and those admitted on a weekday were 28% (42/150) and 17% (204/1190), respectively. After an adjustment for covariates, weekend admission was associated with a significantly higher risk of in-hospital mortality than weekday admission (HR 1.70, 95%CI: 1.20-2.40; p=0.003). However, such an association was not observed in patients treated in a bio-clean room (HR 1.26, 95%CI: 0.65-2.42). Our results demonstrate that for patients with AML, weekend admission was independently associated with a higher risk of death during hospitalization. An appropriate system is necessary for these patients.

周末入院对患者死亡率的影响已经在多个治疗领域进行了研究,包括急性髓性白血病(AML),但研究结果存在争议。我们对2014年4月至2019年3月期间出院的144家急症医院的管理数据进行了一项回顾性观察研究,评估了日本成年AML患者的住院死亡率与周末入院率之间的关系。主要终点是住院死亡率,比较周末和工作日入院人数。在1340例符合条件的患者中,11%(150例)在周末入院。周末住院患者住院死亡率为28%(42/150),工作日住院患者住院死亡率为17%(204/1190)。对协变量进行调整后,周末入院的住院死亡率风险明显高于工作日入院(HR 1.70, 95%CI: 1.20-2.40; p=0.003)。然而,在生物洁净室治疗的患者中没有观察到这种关联(HR 1.26, 95%CI: 0.65-2.42)。我们的研究结果表明,对于急性髓系白血病患者,周末入院与住院期间较高的死亡风险独立相关。对这些病人来说,适当的系统是必要的。
{"title":"Association of Weekend Admission and In-Hospital Mortality in Adult Patients with Acute Myeloid Leukemia in Japan.","authors":"Takahiro Inoue, Hiroyo Kuwabara, Koh Yamamoto","doi":"10.18926/AMO/69845","DOIUrl":"10.18926/AMO/69845","url":null,"abstract":"<p><p>The effect of weekend admission on patient mortality has been investigated in several therapeutic areas, including acute myeloid leukemia (AML), but the investigations' results are controversial. We evaluated the relationship between in-hospital mortality and weekend admission in adult patients with AML in Japan by conducting a retrospective observational study using administrative data from 144 acute care hospitals from which patients were discharged between April 2014 and March 2019. The primary endpoint was in-hospital mortality, compared between weekend and weekday admissions. Among the 1,340 eligible patients, 11% (150) were admitted during a weekend. The in-hospital mortality rates of the patients admitted during weekends and those admitted on a weekday were 28% (42/150) and 17% (204/1190), respectively. After an adjustment for covariates, weekend admission was associated with a significantly higher risk of in-hospital mortality than weekday admission (HR 1.70, 95%CI: 1.20-2.40; p=0.003). However, such an association was not observed in patients treated in a bio-clean room (HR 1.26, 95%CI: 0.65-2.42). Our results demonstrate that for patients with AML, weekend admission was independently associated with a higher risk of death during hospitalization. An appropriate system is necessary for these patients.</p>","PeriodicalId":7017,"journal":{"name":"Acta medica Okayama","volume":"79 6","pages":"431-436"},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145825623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta medica Okayama
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1